These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

672 related items for PubMed ID: 27415008

  • 1. CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART.
    Fromentin R, Bakeman W, Lawani MB, Khoury G, Hartogensis W, DaFonseca S, Killian M, Epling L, Hoh R, Sinclair E, Hecht FM, Bacchetti P, Deeks SG, Lewin SR, Sékaly RP, Chomont N.
    PLoS Pathog; 2016 Jul; 12(7):e1005761. PubMed ID: 27415008
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA.
    Martin GE, Pace M, Thornhill JP, Phetsouphanh C, Meyerowitz J, Gossez M, Brown H, Olejniczak N, Lwanga J, Ramjee G, Kaleebu P, Porter K, Willberg CB, Klenerman P, Nwokolo N, Fox J, Fidler S, Frater J.
    Front Immunol; 2018 Jul; 9():928. PubMed ID: 29780387
    [Abstract] [Full Text] [Related]

  • 5. Single-cell characterization and quantification of translation-competent viral reservoirs in treated and untreated HIV infection.
    Pardons M, Baxter AE, Massanella M, Pagliuzza A, Fromentin R, Dufour C, Leyre L, Routy JP, Kaufmann DE, Chomont N.
    PLoS Pathog; 2019 Feb; 15(2):e1007619. PubMed ID: 30811499
    [Abstract] [Full Text] [Related]

  • 6. Increased homeostatic cytokines and stability of HIV-infected memory CD4 T-cells identify individuals with suboptimal CD4 T-cell recovery on-ART.
    Pino M, Pereira Ribeiro S, Pagliuzza A, Ghneim K, Khan A, Ryan E, Harper JL, King CT, Welbourn S, Micci L, Aldrete S, Delman KA, Stuart T, Lowe M, Brenchley JM, Derdeyn CA, Easley K, Sekaly RP, Chomont N, Paiardini M, Marconi VC.
    PLoS Pathog; 2021 Aug; 17(8):e1009825. PubMed ID: 34449812
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. CD32+ and PD-1+ Lymph Node CD4 T Cells Support Persistent HIV-1 Transcription in Treated Aviremic Individuals.
    Noto A, Procopio FA, Banga R, Suffiotti M, Corpataux JM, Cavassini M, Riva A, Fenwick C, Gottardo R, Perreau M, Pantaleo G.
    J Virol; 2018 Oct 15; 92(20):. PubMed ID: 29976671
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immune activation and exhaustion marker expression on T-cell subsets in ART-treated adolescents and young adults with perinatal HIV-1 infection as correlates of viral persistence.
    Huang Y, Dhummakupt A, Khetan P, Nilles T, Zhou W, Mudvari P, Szewczyk J, Chen YH, Boritz E, Ji H, Agwu A, Persaud D.
    Front Immunol; 2023 Oct 15; 14():1007626. PubMed ID: 37033916
    [Abstract] [Full Text] [Related]

  • 12. Persistence of integrated HIV DNA in CXCR3 + CCR6 + memory CD4+ T cells in HIV-infected individuals on antiretroviral therapy.
    Khoury G, Anderson JL, Fromentin R, Hartogenesis W, Smith MZ, Bacchetti P, Hecht FM, Chomont N, Cameron PU, Deeks SG, Lewin SR.
    AIDS; 2016 Jun 19; 30(10):1511-20. PubMed ID: 26807971
    [Abstract] [Full Text] [Related]

  • 13. Differentiation into an Effector Memory Phenotype Potentiates HIV-1 Latency Reversal in CD4+ T Cells.
    Kulpa DA, Talla A, Brehm JH, Ribeiro SP, Yuan S, Bebin-Blackwell AG, Miller M, Barnard R, Deeks SG, Hazuda D, Chomont N, Sékaly RP.
    J Virol; 2019 Dec 15; 93(24):. PubMed ID: 31578289
    [Abstract] [Full Text] [Related]

  • 14. Targeting Immune Checkpoint Molecules to Eliminate Latent HIV.
    Boyer Z, Palmer S.
    Front Immunol; 2018 Dec 15; 9():2339. PubMed ID: 30459753
    [Abstract] [Full Text] [Related]

  • 15. Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection.
    Hoffmann M, Pantazis N, Martin GE, Hickling S, Hurst J, Meyerowitz J, Willberg CB, Robinson N, Brown H, Fisher M, Kinloch S, Babiker A, Weber J, Nwokolo N, Fox J, Fidler S, Phillips R, Frater J, SPARTAC and CHERUB Investigators.
    PLoS Pathog; 2016 Jul 15; 12(7):e1005661. PubMed ID: 27415828
    [Abstract] [Full Text] [Related]

  • 16. Soluble immune checkpoints as correlates for HIV persistence and T cell function in people with HIV on antiretroviral therapy.
    Chiu CY, Schou MD, McMahon JH, Deeks SG, Fromentin R, Chomont N, Wykes MN, Rasmussen TA, Lewin SR.
    Front Immunol; 2023 Jul 15; 14():1123342. PubMed ID: 37056754
    [Abstract] [Full Text] [Related]

  • 17. T cell immune discriminants of HIV reservoir size in a pediatric cohort of perinatally infected individuals.
    Rinaldi S, de Armas L, Dominguez-Rodríguez S, Pallikkuth S, Dinh V, Pan L, Gӓrtner K, Pahwa R, Cotugno N, Rojo P, Nastouli E, Klein N, Foster C, De Rossi A, Giaquinto C, Rossi P, Palma P, Pahwa S, EPIICAL consortium.
    PLoS Pathog; 2021 Apr 15; 17(4):e1009533. PubMed ID: 33901266
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cardiac morbidity in HIV infection is associated with checkpoint inhibitor LAG-3 on CD4 T cells.
    Pallikkuth S, Pahwa R, Kausalya B, Saravanan S, Pan L, Vignesh R, Iqbal S, Solomon SS, Murugavel KG, Poongulali S, Kumarasamy N, Pahwa S.
    PLoS One; 2018 Apr 15; 13(10):e0206256. PubMed ID: 30379878
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.